Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-044959

Co-Chief Executive Officer gave up 587 shares (to pay taxes)

  • Co-Chief Executive Officer acquired 1,562 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
WEST MICHAEL D Co-Chief Executive Officer 2017-07-10 Option exercise +1,562 881,451 D
WEST MICHAEL D Co-Chief Executive Officer 2017-07-10 Shares withheld for taxes −587 $3.09 $1,814 880,864 D
Derivatives
WEST MICHAEL D Co-Chief Executive Officer 2017-07-10 Option exercise · Restricted Stock Units −1,562 17,188 D
Loading xslF345X03/doc4.xml…